 Central Nervous System Stimulants
"Central Nervous System Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here.
| Descriptor ID |
D000697
|
| MeSH Number(s) |
D27.505.696.282 D27.505.954.427.220
|
| Concept/Terms |
Analeptics- Analeptics
- Analeptic Drugs
- Drugs, Analeptic
- Analeptic Agents
- Agents, Analeptic
|
Below are MeSH descriptors whose meaning is more general than "Central Nervous System Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Central Nervous System Stimulants".
This graph shows the total number of publications written about "Central Nervous System Stimulants" by people in this website by year, and whether "Central Nervous System Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 3 | 0 | 3 | | 2000 | 1 | 0 | 1 | | 2002 | 0 | 1 | 1 | | 2003 | 1 | 1 | 2 | | 2004 | 5 | 3 | 8 | | 2005 | 1 | 2 | 3 | | 2006 | 2 | 3 | 5 | | 2007 | 6 | 4 | 10 | | 2008 | 2 | 2 | 4 | | 2009 | 6 | 2 | 8 | | 2010 | 4 | 0 | 4 | | 2011 | 7 | 3 | 10 | | 2012 | 4 | 3 | 7 | | 2013 | 4 | 2 | 6 | | 2014 | 2 | 2 | 4 | | 2015 | 3 | 1 | 4 | | 2016 | 4 | 2 | 6 | | 2017 | 3 | 1 | 4 | | 2018 | 5 | 2 | 7 | | 2019 | 3 | 0 | 3 | | 2020 | 6 | 0 | 6 | | 2021 | 4 | 0 | 4 | | 2022 | 4 | 0 | 4 | | 2023 | 4 | 0 | 4 | | 2024 | 1 | 2 | 3 | | 2025 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Central Nervous System Stimulants" by people in Profiles.
-
Cembellin-Kao A, Aldy K, Brent J, Culbreth R, LaBozzetta C, Turcios MA, Wax P, Yonamine C, Stolbach A. Occult bromazolam exposure in patients presenting with opioid or stimulant overdose. Clin Toxicol (Phila). 2025 May; 63(5):330-336.
-
Barocas JA, Erdman EA, Westfall MY, Christine PJ, Bernson D, Villani J, Doogan NJ, White L, Walley AY, Bettano A, Wang J. Prevalence of adults with stimulant misuse and/or stimulant use disorder in Massachusetts, USA, 2014-2021. Addiction. 2025 Apr; 120(4):711-720.
-
Metcalf CA, Page CE, Stocker BOS, Johnson RL, Duffy KA, Sammel MD, Loughead J, Epperson CN. Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine. Gynecol Oncol. 2024 Nov; 190:62-69.
-
Camfield K, Reedy A, Wolf C, Al-Tayyib A, Rinehart D, Simpson SA. Diagnosis of methamphetamine-induced psychotic disorder: Findings of an expert consensus panel. Early Interv Psychiatry. 2024 Dec; 18(12):1015-1021.
-
Rockhill KM, Olson R, Dart RC, Iwanicki JL, Black JC. Differing Behaviors Around Adult Nonmedical Use of Prescription Stimulants and Opioids: Latent Class Analysis. J Med Internet Res. 2023 09 20; 25:e46742.
-
Blum NJ, Shults J, Barbaresi W, Bax A, Cacia J, Deavenport-Saman A, Friedman S, Loe IM, Mittal S, Vanderbilt D, LaRosa A, Harstad E. Do Externalizing and Internalizing Symptoms Moderate Medication Response in Preschool Attention-Deficit/Hyperactivity Disorder? A DBPNet Study. J Dev Behav Pediatr. 2023 09 01; 44(7):e447-e454.
-
Pujalte GGA, Narducci DM, Smith MS, King R, Logan K, Callender SS, Liebman CA, Kane SF, Israel MP, Wolf SF, Nuti R, Khodaee M. Athletes With Attention-Deficit/Hyperactivity Disorder: Position Statement of the American Medical Society for Sports Medicine. Clin J Sport Med. 2023 05 01; 33(3):195-208.
-
Bushnell G, Sun JW, dosReis S, Camelo Castillo W, Czaja AS, Durrieu G, Gerhard T, Lee H, Kaguelidou F, Pudasainee-Kapri S, Raman SR, Spence O, Horton DB. Geographic Trends in Pediatric Psychotropic Medication Dispensing Before and After the Start of the COVID-19 Pandemic. Psychiatr Serv. 2023 08 01; 74(8):880-884.
-
Bachtell RK, Larson TA, Winkler MC. Adenosine receptor stimulation inhibits methamphetamine-associated cue seeking. J Psychopharmacol. 2023 02; 37(2):192-203.
-
Deavenport-Saman A, Vanderbilt DL, Harstad E, Shults J, Barbaresi W, Bax A, Cacia J, Friedman S, LaRosa A, Loe I, Mittal S, Blum N. Association of Coexisting Conditions, Attention-Deficit/Hyperactivity Disorder Medication Choice, and Likelihood of Improvement in Preschool-Age Children: A Developmental Behavioral Pediatrics Research Network Study. J Child Adolesc Psychopharmacol. 2022 08; 32(6):328-336.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|